2-フェニル-4-オキソ-4H-1-ベンゾピラン-8-酢酸

Flavone-8-Acetic Acid

HCID 55748CAS 87626-55-9

基本情報

標準SMILES
O=C(O)Cc1cccc2c(=O)cc(-c3ccccc3)oc12
InChIKey
TZZNWMJZDWYJAZ-UHFFFAOYSA-N
分子式
C17H12O4
平均分子量
280.27 g/mol
単同位体質量
280.07355886

概要

Mitoflaxone is a small molecule drug. Mitoflaxone has a monoisotopic molecular weight of 280.07 Da.

名称と識別子

優先名称
Flavone-8-Acetic Acid
IUPAC
2-(4-oxo-2-phenylchromen-8-yl)acetic acid
現地名
2-フェニル-4-オキソ-4H-1-ベンゾピラン-8-酢酸
英語名
Mitoflaxone
分子式
C17H12O4
分子量
280.27

名称と別名

MitoflaxoneFlavone acetic acid87626-55-9flavone-8-acetic acidLM-975MitoflaxonaNSC-347512MitoflaxonumNSC 3475124-Oxo-2-phenyl-4H-1-benzopyran-8-acetic acidNSC3475124H-1-BENZOPYRAN-8-ACETIC ACID, 4-OXO-2-PHENYL-
名称をさらに表示
ミトフラキソン2-フェニル-4-オキソ-4H-1-ベンゾピラン-8-酢酸4-オキソ-2-フェニル-4H-1-ベンゾピラン-8-酢酸フラボン-8-酢酸酢酸フラボンフラボン酢酸マイトフラキソン2-(4-オキソ-2-フェニル-4H-クロメン-8-イル)酢酸NSC-37512FLAVONE-8-ACETICACID2-(4-oxo-2-phenylchromen-8-yl)acetic acid2-(4-oxo-2-phenyl-4H-chromen-8-yl)acetic acid(WXG00880)
2-Phenyl-8-(carboxymethyl)-benzopyran-4-oneDTXSID50236534X230G6E63BRefChem:159087DTXCID80159025(4-Oxo-2-phenyl-4H-chromen-8-yl)-acetic acid4H-1-benzopyran-8-acetic Acid, 4-Oxo-2-phenylMitoflaxone [INN]

データベース識別子

CAS
87626-55-9
PubChem CID
55748
DTXSID
DTXSID50236534
ChEMBL
CHEMBL443793
UNII
X230G6E63B
Nikkaji
J227.455H

物性

構造計算による物性

XLogP
3
極性表面積
63.6 Ų
水素結合供与体数
1
水素結合受容体数
4
回転可能結合数
3
重原子数
21

実験および物理化学的性質

Solubility · 6 件

Water < 0.1 (mg/mL)

0.1 N NaOH ~20 (mg/mL)

0.1 N HCl < 0.1 (mg/mL)

0.1 M NaHCO3 < 0.3 (mg/mL)

95% EtOH 1 (mg/mL)

MeOH 1 (mg/mL)

Stability/Shelf LifeBulk: As a bulk chemical, Flavone -8- acetic acid is stable for at least 3 months at 60 °C (HPLC). Solution: Solutions of 1 mg/mL dissolved in 0.1 N NaOH (pH 9) showed no decomposition for at least 27 hours.

物理化学的性質

融点
234 °C · 234 °C(Solv: ethanol (64-17-5))
沸点
507.9 · 507.9±50.0 °C(Predicted)
比重(密度)
1.355 · 1.355±0.06 g/cm3(Predicted)
酸解離定数(Pka)
4.16 · 4.16±0.10(Predicted)

化学と産業

薬理情報

MeSH Pharmacological Classification · 2 件

Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.

Substances that inhibit or prevent the proliferation of NEOPLASMS.

サプライヤー6 社

杭州摩库生物医药科技有限公司+86-057181025280; +8617767106207 · [email protected]
Hangzhou Sage Chemical Co., Ltd.+86057186818502 13588463833 · [email protected]
上海永叶生物科技有限公司86-021-61559134 15921386130 · [email protected]
上海澄绍生物科技有限公司021-61847300 13341622919 · [email protected]
南京尚书生物科技有限公司18266960953 · [email protected]

関連反応

1 件

関連ノート

読み込み中…